These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4561333)

  • 1. Clinical trial of 2-Br- -ergocryptine (CB154) in advanced breast cancer.
    Eur J Cancer (1965); 1972 Apr; 8(2):155-6. PubMed ID: 4561333
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 2-Br-alpha-Ergocryptine, L-dopa and cyclic imides on serum prolactin in postmenopausal women.
    Rozencweig M; Heuson JC; Bila S; L'Hermite M; Robyn C
    Eur J Cancer (1965); 1973 Sep; 9(9):657-64. PubMed ID: 4803232
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-lasting anti-tremor induced by 2-Br-alpha-ergocryptine in monkeys.
    Miyamoto T; Battista A; Goldstein M; Fuxe K
    J Pharm Pharmacol; 1974 Jun; 26(6):452-4. PubMed ID: 4154991
    [No Abstract]   [Full Text] [Related]  

  • 4. [Postpartal lactation inhibition by 2-Br-alpha-ergocryptine: I. A comparative study with 2-Br-alpha-ergocryptine in different dosages and placebo (author's transl)].
    Varga L; Radielovic P
    Geburtshilfe Frauenheilkd; 1974 Oct; 34(10):882-4. PubMed ID: 4613600
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolactin and breast cancer.
    Lancet; 1972 Nov; 2(7787):1129-30. PubMed ID: 4117209
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proceedings: Comparative animal experiments on the effectivity of various endocrine therapeutic methods in hormone dependent breast carcinoma].
    Schulz KD; Ahrens J
    Arch Gynakol; 1973 Sep; 214(1):296-7. PubMed ID: 4801462
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advances in the treatment of the galactorrhoea-amenorrhoea-syndrome: Induction of ovulation and inhibition of lactation with 2-Br-alpha-ergo-cryptine (author's transl)].
    Jaszmann L; Sternthal V
    Geburtshilfe Frauenheilkd; 1974 Jan; 34(1):59-64. PubMed ID: 4816922
    [No Abstract]   [Full Text] [Related]  

  • 8. Successufl ovulation and pregnancy achieved by cb-154 (2-br-alpha-ergocryptine) in a woman with Chiari-Frommel syndrome.
    Seki K; Seki M
    J Clin Endocrinol Metab; 1974 Mar; 38(3):598-9. PubMed ID: 4815181
    [No Abstract]   [Full Text] [Related]  

  • 9. An ergocryptine as a lactation inhibitor.
    Falzon MD; Galea R; Cmailleri AP
    Gynecol Invest; 1974; 5(3):133-8. PubMed ID: 4615051
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial of the cyclic imide 1-(morpholinomethyl)-4-phtalimido-piperidindione-2,6 (CG 603) in advanced breast cancer.
    Eur J Cancer (1965); 1972 Apr; 8(2):157-8. PubMed ID: 4561334
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.
    Varga L; Lutterbeck PM; Pryor JS; Wenner R; Erb H
    Br Med J; 1972 Jun; 2(5816):743-4. PubMed ID: 4556543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postpartal lactation inhibition by 2-Br-alpha-ergocryptine: II. A comparative study with 2-Br-alpha-ergocryptine and methallenoestrol (author's transl)].
    Varga L; Radielovic P
    Geburtshilfe Frauenheilkd; 1974 Oct; 34(10):885-7. PubMed ID: 4442688
    [No Abstract]   [Full Text] [Related]  

  • 13. Two-bromo- -ergocryptine (CB 154) inhibition of prolactin secretion and galactorrhoea in a case of pituitary tumour.
    Copinschi G; L'Hermite M; Pasteels JL; Robyn C
    Gynecol Invest; 1971; 2(1):128-9. PubMed ID: 5170651
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): restoration of ovulatory function and fertility.
    Varga L; Wenner R; Del Pozo E
    Am J Obstet Gynecol; 1973 Sep; 117(1):75-9. PubMed ID: 4722381
    [No Abstract]   [Full Text] [Related]  

  • 15. Stable reduction of plasma growth hormone (hGH) levels during chronic administration of 2-Br-alpha-ergocryptine (CB-154) in acromegalic patients.
    Chiodini PG; Liuzzi A; Botalla L; Oppizzi G; Müller EE; Silvestrini F
    J Clin Endocrinol Metab; 1975 Apr; 40(4):705-8. PubMed ID: 1127079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation.
    Fuxe K; Corrodi H; Hökfelt T; Lidbrink P; Ungerstedt U
    Med Biol; 1974 Apr; 52(2):121-32. PubMed ID: 4837435
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolactin inhibition and suppression of puerperal lactation by a Br-erocryptine (CB 154). A comparison with estrogen.
    Brun del Re R; Del Pozo E; De Grandi P; Friesen H; Hinselmann M; Wyss H
    Obstet Gynecol; 1973 Jun; 41(6):884-90. PubMed ID: 4708482
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term treatment of galactorrhoea and hypogonadism with bromocriptine.
    Thorner MO; McNeilly AS; Hagan C; Besser GM
    Br Med J; 1974 May; 2(5916):419-22. PubMed ID: 4600593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of thyrotropin and prolactin secretions in primary hypothyroidism by 2-Br-alpha-ergocryptine.
    Miyal K; Onishi T; Hosokawa M; Ishibashi K; Kumahara Y
    J Clin Endocrinol Metab; 1974 Aug; 39(2):391-4. PubMed ID: 4418165
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
    Martínez-López JM; Calvo-Fernández R; Garrido-Toro A; Sánchez-Cañaveral F
    Angiologia; 1973; 25(4):195-8. PubMed ID: 4717702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.